Correction To: High tumor mutational burden assessed through next‑generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients
J Transl Med. 2025 Jan 8;23(1):28.
doi: 10.1186/s12967-024-05971-5.
1 Pathology Unit, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", via M. Semmola, Naples, 80131, Italy.
2 Structure of Innovative Therapies for Abdominal Metastases, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", via M. Semmola, Naples, 80131, Italy.
3 AMES, Centro Polidiagnostico Strumentale Srl, Naples, 80013, Italy.
4 Department of Precision Medicine, University of Campania "L. Vanvitelli", Via L. de Crecchio, 7, Naples, 80138, Italy.
5 Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic Research, Ariano Irpino, Italy.
6 Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica del Sacro Cuore, Rome, Italy.
7 Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, 84081, Italy.
8 Department of Medicine and Surgery, LUM University "Giuseppe Degennaro", Bari, Italy.
9 Department of Precision Medicine, University of Campania "L. Vanvitelli", Via L. de Crecchio, 7, Naples, 80138, Italy. michele.caraglia@unicampania.it.
10 Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic Research, Ariano Irpino, Italy. michele.caraglia@unicampania.it.
11 Structure of Innovative Therapies for Abdominal Metastases, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", via M. Semmola, Naples, 80131, Italy. a.ottaiano@istitutotumori.na.it.